WDH1 Stock Overview
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Demant A/S Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr.43.24 |
52 Week High | kr.49.87 |
52 Week Low | kr.33.82 |
Beta | 0.91 |
1 Month Change | -6.47% |
3 Month Change | 4.95% |
1 Year Change | 12.60% |
3 Year Change | 4.24% |
5 Year Change | 53.33% |
Change since IPO | 620.67% |
Recent News & Updates
Recent updates
Shareholder Returns
WDH1 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 4.2% | -0.6% | 1.8% |
1Y | 12.6% | -9.5% | 2.2% |
Return vs Industry: WDH1 exceeded the German Medical Equipment industry which returned -9.5% over the past year.
Return vs Market: WDH1 exceeded the German Market which returned 2.2% over the past year.
Price Volatility
WDH1 volatility | |
---|---|
WDH1 Average Weekly Movement | 4.4% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: WDH1 has not had significant price volatility in the past 3 months.
Volatility Over Time: WDH1's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1904 | 21,623 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Demant A/S Fundamentals Summary
WDH1 fundamental statistics | |
---|---|
Market cap | €9.36b |
Earnings (TTM) | €342.15m |
Revenue (TTM) | €3.01b |
27.4x
P/E Ratio3.1x
P/S RatioIs WDH1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WDH1 income statement (TTM) | |
---|---|
Revenue | kr.22.44b |
Cost of Revenue | kr.5.90b |
Gross Profit | kr.16.54b |
Other Expenses | kr.13.99b |
Earnings | kr.2.55b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 06, 2024
Earnings per share (EPS) | 11.72 |
Gross Margin | 73.72% |
Net Profit Margin | 11.37% |
Debt/Equity Ratio | 126.0% |
How did WDH1 perform over the long term?
See historical performance and comparison